135 related articles for article (PubMed ID: 17234158)
1. Pirfenidone inhibits TGF-beta expression in malignant glioma cells.
Burghardt I; Tritschler F; Opitz CA; Frank B; Weller M; Wick W
Biochem Biophys Res Commun; 2007 Mar; 354(2):542-7. PubMed ID: 17234158
[TBL] [Abstract][Full Text] [Related]
2. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
3. BCL-2-induced glioma cell invasiveness depends on furin-like proteases.
Wick W; Wild-Bode C; Frank B; Weller M
J Neurochem; 2004 Dec; 91(6):1275-83. PubMed ID: 15584904
[TBL] [Abstract][Full Text] [Related]
4. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P
Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
[TBL] [Abstract][Full Text] [Related]
5. Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells.
Gramatzki D; Pantazis G; Schittenhelm J; Tabatabai G; Köhle C; Wick W; Schwarz M; Weller M; Tritschler I
Oncogene; 2009 Jul; 28(28):2593-605. PubMed ID: 19465936
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.
Tran TT; Uhl M; Ma JY; Janssen L; Sriram V; Aulwurm S; Kerr I; Lam A; Webb HK; Kapoun AM; Kizer DE; McEnroe G; Hart B; Axon J; Murphy A; Chakravarty S; Dugar S; Protter AA; Higgins LS; Wick W; Weller M; Wong DH
Neuro Oncol; 2007 Jul; 9(3):259-70. PubMed ID: 17522330
[TBL] [Abstract][Full Text] [Related]
7. Decorin gene transfer-mediated suppression of TGF-beta synthesis abrogates experimental malignant glioma growth in vivo.
Ständer M; Naumann U; Dumitrescu L; Heneka M; Löschmann P; Gulbins E; Dichgans J; Weller M
Gene Ther; 1998 Sep; 5(9):1187-94. PubMed ID: 9930319
[TBL] [Abstract][Full Text] [Related]
8. Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis.
Iyer SN; Gurujeyalakshmi G; Giri SN
J Pharmacol Exp Ther; 1999 Oct; 291(1):367-73. PubMed ID: 10490926
[TBL] [Abstract][Full Text] [Related]
9. Glioma gene therapy with soluble transforming growth factor-beta receptors II and III.
Naumann U; Maass P; Gleske AK; Aulwurm S; Weller M; Eisele G
Int J Oncol; 2008 Oct; 33(4):759-65. PubMed ID: 18813789
[TBL] [Abstract][Full Text] [Related]
10. Pirfenidone inhibits the expression of HSP47 in TGF-beta1-stimulated human lung fibroblasts.
Nakayama S; Mukae H; Sakamoto N; Kakugawa T; Yoshioka S; Soda H; Oku H; Urata Y; Kondo T; Kubota H; Nagata K; Kohno S
Life Sci; 2008 Jan; 82(3-4):210-7. PubMed ID: 18093617
[TBL] [Abstract][Full Text] [Related]
11. Expression of collagenase-1 (MMP-1) promotes melanoma growth through the generation of active transforming growth factor-beta.
Iida J; McCarthy JB
Melanoma Res; 2007 Aug; 17(4):205-13. PubMed ID: 17625450
[TBL] [Abstract][Full Text] [Related]
12. The experimental agent pirfenidone reduces pro-fibrotic gene expression in a model of tacrolimus-induced nephrotoxicity.
Brook NR; Waller JR; Bicknell GR; Nicholson ML
J Surg Res; 2005 May; 125(2):137-43. PubMed ID: 15854665
[TBL] [Abstract][Full Text] [Related]
13. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.
Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B
Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491
[TBL] [Abstract][Full Text] [Related]
14. Expression of decorin in esophageal cancer in relation to the expression of three isoforms of transforming growth factor-beta (TGF-beta1, -beta2, and -beta3) and matrix metalloproteinase-2 activity.
Augoff K; Grabowski K; Rabczynski J; Kolondra A; Tabola R; Sikorski AF
Cancer Invest; 2009 May; 27(4):443-52. PubMed ID: 19212830
[TBL] [Abstract][Full Text] [Related]
15. Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape.
Platten M; Wick W; Weller M
Microsc Res Tech; 2001 Feb; 52(4):401-10. PubMed ID: 11170299
[TBL] [Abstract][Full Text] [Related]
16. Effects of pirfenidone on proliferation, migration, and collagen contraction of human Tenon's fibroblasts in vitro.
Lin X; Yu M; Wu K; Yuan H; Zhong H
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3763-70. PubMed ID: 19264889
[TBL] [Abstract][Full Text] [Related]
17. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K
Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta-induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF)2 in human breast epithelial cells.
Kim ES; Sohn YW; Moon A
Cancer Lett; 2007 Jul; 252(1):147-56. PubMed ID: 17258390
[TBL] [Abstract][Full Text] [Related]
19. Extracts of Lindera obtusiloba induce antifibrotic effects in hepatic stellate cells via suppression of a TGF-beta-mediated profibrotic gene expression pattern.
Ruehl M; Erben U; Kim K; Freise C; Dagdelen T; Eisele S; Trowitzsch-Kienast W; Zeitz M; Jia J; Stickel F; Somasundaram R
J Nutr Biochem; 2009 Aug; 20(8):597-606. PubMed ID: 18824344
[TBL] [Abstract][Full Text] [Related]
20. Potent antioxidant role of pirfenidone in experimental cirrhosis.
Salazar-Montes A; Ruiz-Corro L; López-Reyes A; Castrejón-Gómez E; Armendáriz-Borunda J
Eur J Pharmacol; 2008 Oct; 595(1-3):69-77. PubMed ID: 18652820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
